The Use of Antidepressants and the Risk of Idiopathic Pulmonary Arterial Hypertension

Canadian Journal of Cardiology

Volumn 30, Issue 12, 2014, Pages 1633-1639

  Fox, Benjamin D ^a,b,c   Azoulay, Laurent ^a,d   Dell'Aniello, Sophie ^a   Langleben, David ^b   Lapi, Francesco ^a,e   Benisty, Jacques ^a   Suissa, Samy ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c TEL AVIV UNIVERSITY   (Israel)

^d MCGILL UNIVERSITY   (Canada)

^e UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; NORADRENALIN TRANSPORTER; SEROTONIN; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; FEMALE; GENERAL PRACTICE; HUMAN; MAJOR CLINICAL STUDY; MALE; PULMONARY HYPERTENSION; RISK; RISK ASSESSMENT; SEROTONIN RELEASE; UNITED KINGDOM; CHEMICALLY INDUCED; CLINICAL TRIAL; CONFIDENCE INTERVAL; DEPRESSION; FAMILIAL PRIMARY PULMONARY HYPERTENSION; FOLLOW UP; INCIDENCE; MIDDLE AGED; MULTICENTER STUDY; RETROSPECTIVE STUDY; RISK FACTOR;

ANTIDEPRESSIVE AGENTS; CONFIDENCE INTERVALS; DEPRESSION; FAMILIAL PRIMARY PULMONARY HYPERTENSION; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84919845550     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2014.09.031     Document Type: Article

References (28)

1. McLaughlin V.V., Archer S.L., Badesch D.B., et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation 2009, 119:2250-2294.
2. Abenhaim L., Moride Y., Brenot F., et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. NEngl J Med 1996, 335:609-616.
3. Adnot S. The serotonin system as a therapeutic target in pulmonary hypertension. Textbook of Pulmonary Vascular Disease 2011, 1501-1507. Springer, New York. J.X.J. Yuan, J.G.N. Garcia, J.B. West (Eds.).
4. Tatsumi M., Groshan K., Blakely R.D., Richelson E. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 1997, 340:249-258.
5. Shah S.J., Gomberg-Maitland M., Thenappan T., Rich S. Selective serotonin reuptake inhibitors and the incidence and outcome of pulmonary hypertension. Chest 2009, 136:694-700.
6. Dhalla I.A., Juurlink D.N., Gomes T., et al. Selective serotonin reuptake inhibitors and pulmonary arterial hypertension: a case-control study. Chest 2012, 141:348-353.
7. Ventetuolo C.E., Barr R.G., Bluemke D.A., et al. Selective serotonin reuptake inhibitor use is associated with right ventricular structure and function: the MESA-right ventricle study. PLoS One 2012, 7:e30480.
8. Sadoughi A., Roberts K.E., Preston I.R., et al. Use of selective serotonin reuptake inhibitors and outcomes in pulmonary arterial hypertension. Chest 2013, 144:531-541.
9. von Elm E., Altman D.G., Egger M., et al. STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. BMJ 2007, 335:806-808.
10. Walley T., Mantgani A. The UK General Practice Research Database. Lancet 1997, 350:1097-1099.
11. Rodríguez L.A.G., Gutthann S.P. Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol 1998, 45:419-425.
12. Jick S.S., Kaye J.A., Vasilakis-Scaramozza C., et al. Validity of the general practice research database. Pharmacotherapy 2003, 23:686-689.
13. Lawrenson R., Todd J.C., Leydon G.M., Williams T.J., Farmer R.D. Validation of the diagnosis of venous thromboembolism in general practice database studies. Br J Clin Pharmacol 2000, 49:591-596.
14. Lawrenson R., Williams T., Farmer R. Clinical information for research; the use of general practice databases. JPublic Health Med 1999, 21:299-304.
15. Landis J.R., Koch G.G. The measurement of observer agreement for categorical data. Biometrics 1977, 33:159-174.
16. Horwitz R.I., Feinstein A.R. The problem of "protopathic bias" in case-control studies. Am J Med 1980, 68:255-258.
17. Suissa S. Novel approaches to pharmacoepidemiology study design and statistical analysis. Pharmacoepidemiology 2007, 811-829. Wiley, Chichester, UK. B.L. Strom (Ed.).
18. Essebag V., Platt R.W., Abrahamowicz M., Pilote L. Comparison of nested case-control and survival analysis methodologies for analysis of time-dependent exposure. BMC Med Res Methodol 2005, 5:5.
19. Essebag V., Genest J., Suissa S., Pilote L. The nested case-control study in cardiology. Am Heart J 2003, 146:581-590.
20. McCollister D.H., Beutz M., McLaughlin V., et al. Depressive symptoms in pulmonary arterial hypertension: prevalence and association with functional status. Psychosomatics 2010, 51:339-339.e8.
21. Looper K.J., Pierre A., Dunkley D.M., Sigal J.J., Langleben D. Depressive symptoms in relation to physical functioning in pulmonary hypertension. JPsychosom Res 2009, 66:221-225.
22. Löwe B., Gräfe K., Ufer C., et al. Anxiety and depression in patients with pulmonary hypertension. Psychosom Med 2004, 66:831-836.
23. Cao H., Gu H., Qiu W., et al. Association study of serotonin transporter gene polymorphisms and ventricular septal defects related possible pulmonary arterial hypertension in Chinese population. Clin Exp Hypertens 2009, 31:605-614.
24. Ling Y., Johnson M.K., Kiely D.G., et al. Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland. Am J Respir Crit Care Med 2012, 186:790-796.
25. Escribano-Subias P., Blanco I., López-Meseguer M., et al. Survival in pulmonary hypertension in Spain: insights from the Spanish registry. Eur Respir J 2012, 40:596-603.
26. Humbert M., Sitbon O., Chaouat A., et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 2006, 173:1023-1030.
27. Burger C.D., Foreman A.J., Miller D.P., Safford R.E., McGoon M.D., Badesch D.B. Comparison of body habitus in patients with pulmonary arterial hypertension enrolled in the Registry to Evaluate Early and Long-term PAH Disease Management with normative values from the National Health and Nutrition Examination Survey. Mayo Clin Proc 2011, 86:105-112.
28. Suissa S., Patenaude V., Lapi F., Ernst P. Inhaled corticosteroids in COPD and the risk of serious pneumonia. Thorax 2013, 68:1029-1036.